FHTX — FOGHORN THERAPEUTICS INC

Ownership history in Birchview Capital, LP  ·  21 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in FOGHORN THERAPEUTICS INC (FHTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.63% (2021 Q4)
Avg. % of fund
1.98%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 281,730 — 0% 0.89% $1.5M $5.40
2025 Q3 REDUCED 281,730 -29,200 -9.4% 1.04% $1.4M $4.89
2025 Q2 UNCHANGED 310,930 — 0% 1.45% $1.5M $4.70
2025 Q1 UNCHANGED 310,930 — 0% 0.99% $1.1M $3.65
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FHTX price (monthly, adj. close)

Other funds also holding FHTX

As of 2025 Q4 — sorted by position size

Flagship Pioneering, LLC 3Y 7Y 21.12% Euclidean Capital LLC 3Y 2.3% BVF INC/IL 3Y 7Y 0.96% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 0.25% DAFNA Capital Management LLC 3Y 7Y 0.16% Brummer Multi-Strategy AB 0.15% Siren, L.L.C. 0.12% Persistent Asset Partners Ltd 0.11% Sio Capital Management, LLC 3Y 7Y 0.1% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01%
← Back to Birchview Capital, LP Holdings